Longevity: The $101 Million Competition to Hack Aging

Berkeley, California. Jamie Justice, an anti-aging researcher with a superhero-worthy name, left her tenure-track position at Wake Forest University to run the XPRIZE Healthspan—a $101 million global competition to find therapies that restore muscle, cognition, and immune function in older adults. "There's a booming market for slowing aging, but there's no way to tell if [treatments] work," Justice said at the Vitalist Bay longevity conference. The competition selected 10 teams from 40 applicants; their therapies will undergo yearlong randomized controlled clinical trials. The winner will be announced in 2030.

The Science

Aging is a multifactorial process involving senescent cell accumulation, mitochondrial decline, and loss of neuronal plasticity. The XPRIZE Healthspan requires treatments to show improvement in three domains: muscle function, cognition, and immune function. This is unusual—most anti-aging studies focus on a single biomarker.

The 10 finalist teams employ diverse approaches: structured exercise, senolytics (drugs that target damaged "zombie" cells), and personalized medicine based on biomarkers. Justice acknowledges the field attracts "colorful characters with far-out theories"—a man in a purple cape roamed Vitalist Bay—but she advocates a big-tent approach. "As scientists, we have to be really mindful to not turn into gatekeepers," she told STAT.

“The real challenge isn't just finding therapies—it's proving they work in humans over a full year.”

Key Findings

• Global competition: XPRIZE Healthspan offers $101 million in prizes; 10 teams were selected from 40 applicants.
• Rigorous clinical trials: Therapies must pass yearlong randomized controlled trials measuring muscle, cognition, and immunity.
• Diverse approaches: Exercise, senolytics, and personalized medicine are the leading strategies among finalists.
• Timeline: The winner will be announced in 2030, allowing time for robust data collection.
• Scam risk: Justice notes that "purely scammy" companies tarnish the field's reputation.

Why It Matters

Population aging is one of the 21st century's greatest health challenges. Currently, there is no standardized way to evaluate whether an anti-aging treatment works. XPRIZE Healthspan fills that gap by requiring clinical trials with clear endpoints. If any treatment succeeds, it could transform geriatric care—from maintaining functional independence to reducing neurodegenerative disease burden.

Moreover, the competition could catalyze investment in senolytics and personalized medicine. Justice emphasizes that the goal is not immortality but healthspan—years of healthy life. For biohackers, this means we may soon have scientifically validated protocols, not just passing fads.

Your Protocol

While awaiting XPRIZE results, you can take evidence-based steps to optimize your healthspan today:

1. 1Combine exercise types: Incorporate strength training (for muscle) and aerobic exercise (for cognition and cardiovascular health). Studies show both are essential.
2. 2Monitor biomarkers: Get regular blood tests for inflammation (CRP), immune function (white blood cell count), and metabolic health (fasting glucose, HbA1c).
3. 3Consider senolytic candidates: Compounds like fisetin and quercetin have shown senolytic effects in preliminary studies. Consult a physician before supplementing.
4. 4Prioritize sleep: Deep sleep is crucial for brain waste clearance and cellular repair. Aim for 7–9 hours per night.

What To Watch Next

XPRIZE Healthspan clinical trials begin in 2026 and run through 2029. Interim results may be published in peer-reviewed journals. It's also worth following the finalist teams, which include researchers from Harvard, Stanford, and the Buck Institute.

Additionally, Justice hinted that the prize could inspire similar competitions in other domains, like metabolic health or cognitive longevity. The combination of private capital (Diamandis) and academic rigor (Justice) could become a model for accelerating research.

The Bottom Line

The XPRIZE Healthspan is the most ambitious experiment to validate anti-aging therapies. With $101 million at stake and a rigorous clinical trial design, it promises to separate science from scams. Meanwhile, biohackers can adopt an evidence-based approach: exercise, biomarker monitoring, and quality sleep. The future of longevity isn't a magic pill—it's a systematic protocol. And by 2030, we'll know what works.

Additional Context

The XPRIZE Healthspan is not the first longevity competition, but it is the largest. Its predecessor, the XPRIZE for genomics, accelerated DNA sequencing. Now, the goal is to replicate that success in aging research. The involvement of figures like Peter Diamandis, co-founder of XPRIZE, and scientist Jamie Justice ensures a balance of vision and rigor. The 10 finalist teams represent 8 countries, underscoring the global nature of the challenge.

Ethical Implications

The competition also raises ethical questions: who will have access to these therapies if they work? Will they exacerbate existing inequalities? Justice acknowledges these concerns and notes that the prize requires treatments to be affordable and scalable. Additionally, the trials include diverse populations to ensure generalizability. Transparency in data publication will be key to building trust.

Emerging Research

Beyond XPRIZE, the senolytics field is advancing rapidly. Recent mouse studies show that the combination of dasatinib and quercetin can rejuvenate tissues. In humans, small trials have demonstrated safety and preliminary efficacy in conditions like pulmonary fibrosis. XPRIZE could provide the large-scale data needed to validate these findings.

Expert Perspectives

Dr. David Sinclair, a Harvard geneticist and author of "Lifespan," commented: "The XPRIZE Healthspan is exactly what we need—a massive incentive for the best scientists to collaborate and solve hard problems." On the other hand, some critics warn that one-year trials may be insufficient to capture long-term effects. Justice responds that it's a necessary compromise to get rapid results without sacrificing rigor.

How to Get Involved

Biohackers can engage in several ways: following publications from finalist teams, participating in observational studies, or even applying for future XPRIZE rounds. Online longevity communities, such as Reddit forums and Telegram groups, are already discussing strategies to replicate team protocols. However, Justice warns: "Don't try this at home without medical supervision."

Conclusion

The XPRIZE Healthspan represents a unique opportunity to transform our understanding of aging. With rigorous design and generous funding, it could set new standards for geroscience research. Meanwhile, each of us can take steps to improve our own healthspan. The future is promising, but it requires patience and healthy skepticism.